Charles River Laboratories
CRL
707 hedge funds and large institutions have $17.8B invested in Charles River Laboratories in 2021 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 245 increasing their positions, 264 reducing their positions, and 64 closing their positions.
82% more call options, than puts
Call options by funds: $105M | Put options by funds: $57.7M
66% more first-time investments, than exits
New positions opened: 106 | Existing positions closed: 64
4% more funds holding
Funds holding: 677 → 707 (+30)
0.54% more ownership
Funds ownership: 92.91% → 93.45% (+0.54%)
7% less repeat investments, than reductions
Existing positions increased: 245 | Existing positions reduced: 264
8% less capital invested
Capital invested by funds: $19.3B → $17.8B (-$1.57B)
25% less funds holding in top 10
Funds holding in top 10: 20 → 15 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
+$210M |
| 2 |
MCM
Melvin Capital Management
New York
|
+$112M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$82.6M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$59.2M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$51.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$90.1M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$72.1M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$66.6M |
| 4 |
CIM
Confluence Investment Management
St. Louis,
Missouri
|
-$51.8M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$45.1M |
CRL Hedge Fund Activity: Q4 2021 in Review
707 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2021, worth a combined $17.8B — down 8.1% from $19.3B a quarter earlier.
Buyers outnumbered sellers: 106 funds opened new CRL positions and 64 closed out — a net gain of 42 holders — while 245 added to existing stakes and 264 trimmed.
The largest buyer was ClearBridge Investments, adding an estimated $210M. The largest seller was Ameriprise, cutting an estimated $90.1M.
- 707 institutional investors held Charles River Laboratories (CRL) as of Q4 2021, up from 677 in Q3 2021.
- Funds reported $17.8B of Charles River Laboratories stock for Q4 2021, down 8.1% quarter-over-quarter.
- 106 funds opened new Charles River Laboratories positions in Q4 2021 and 64 closed out, a net change of +42 holders.
- The largest Charles River Laboratories buyer in Q4 2021 was ClearBridge Investments, an estimated $210M added.
- The largest Charles River Laboratories seller in Q4 2021 was Ameriprise, an estimated $90.1M sold.
Based on aggregated 13F filings for Q4 2021.